TrialNature communications2024

Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial.

Isabelle L Ray-Coquard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.